ATS 2024 Final Program

Click on the session title to view the speakers

247

TUESDAY • MAY 21

P1178 An Electronic Health Record-based Risk Prediction Model for Methicillin-resistant Staphylococcus Aureus in Adults With Suspected Sepsis P1179 Characteristics and Health Care Outcomes of Patients Diagnosed With Murine Typhus P1180 Efficacy of Inhaled Antibiotics to Prevent Ventilator Associated Pneumonia P1181 The Obesity Paradox in Sepsis: An In-Depth Analysis P1182 Gender Based Disparities in Outcomes of Septic Shock Related Hospitalizations in Solid Organ Transplant Recipients: A Propensity Matched National Study P1183 Epidemiology of Beta Blocker Use Among Critically Ill Patients With Sepsis P1184 Prevalence and Impact of Cannabis Use Disorder on Severe Sepsis and Subsequent Cardiopulmonary Outcomes in Cancer Patients: Insights From National Inpatient Sample, 2016-2020 P1185 Poor Long-term Mortality Following Hospitalization for Sepsis in Cancer Patients P1186 Pre-existing Diabetes Mellitus Is Associated With Increased Risk of Developing Septic Shock in Patients With Acute Cholangitis P1187 Unravelling the Fluid Paradox in End Stage Kidney Disease and Sepsis: A Meta-analysis P1188 Passive Leg Raise Effect on Bioreactance Versus Velocity Time Integral for Fluid Responsiveness in Patients With Moderately Severe ARDS on Mechanical Ventilation in Vasodilatory Shock: A Prospective Observational Validation Study P1189 Determining an Optimal Initial Fluid Resuscitation Strategy for Patients With Sepsis-associated Hypotension and Shock Using Machine Learning and Real-world Evidence P1190 Association Between Adjunctive Vasopressors and Short-term Mortality in Adults With Septic Shock: A Systematic Review and Meta-analysis P1191 Angiotensin 2: Real-world Experience in Cancer Patients With Vasodilatory Shock P1192 Comparative Efficacy and Safety of Different Corticosteroid Regimens for the Management of Sepsis and Septic Shock: Preliminary Results From a Network Meta-Analysis

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

C39 PNEUMONIA AND SEPSIS:

EPIDEMIOLOGY, TREATMENTS, AND OUTCOMES

9:15 a.m. - 4:15 p.m.

San Diego Convention Center Area K (Hall H, Ground Level)

Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendeess P1169 A Comprehensive Analysis of Clinical Outcomes and Demographic Characteristics of Patients With Pseudomonas Aeruginosa Isolated From Respiratory Specimens P1170 Feasibility Report of Observational Longitudinal Study at a Long-term Acute Care Hospital on Tracheobronchitis P1171 Contributing Factors Towards Intensive Care Unit Admission in Patients With Pneumonia and Their Clinical Profile P1172 An Epidemiological Study on Incidence, Predictors, and Prognosis of Ventilator-associated Pneumonia in Intensive Care Unit: A Prospective Cohort Study in Egypt P1173 Communication of Microbiology Results at a Referral Hospital in Western Kenya: A Qualitative Study P1174 The Mouse IL-8 Homologue KC in Plasma Has Predictive Value for the Severity of Bacterial Pneumonia in a Mouse Model of ARDS P1175 Transcriptomic Differences in Septic Patients With Hematopoietic Stem Cell Transplant and Immunocompetent Septic Controls P1176 Value of Monocyte Distribution Width in Bacteremia Assessment in Emergency Department Patients P1177 Procalcitonin as a Diagnostic Biomarker for Early Sepsis in Burn Patients: An Updated Diagnostic Accuracy Meta-analysis

ATS 2024 Conference Program • San Diego, CA